Immunuglobulin A 신질환과 Henoch-Schnlein purpura 신질환을 가진 소아에서의 cyclosporine A와angiotensin-converting enzyme inhibitor 치료의 임상적, 병리학적 변화

Title
Immunuglobulin A 신질환과 Henoch-Schnlein purpura 신질환을 가진 소아에서의 cyclosporine A와angiotensin-converting enzyme inhibitor 치료의 임상적, 병리학적 변화
Other Titles
Clinicopathologic Changes in Children with Immunoglobulin A Nephritis and Henoch-Schönlein Purpura Nephritis after Cyclosporine A and Angiotensin-converting Enzyme Inhibitor Treatment
Author(s)
김용진이정주[이정주]신재일[신재일]임현이[임현이]박세진[박세진]
Keywords
IgA deposit; IgA nephropathy; Henoch-Schönlein purpura nephritis; cyclosporine A
Issue Date
201310
Publisher
대한소아신장학회
Citation
대한소아신장학회지, v.17, no.2, pp.92 - 100
Abstract
Purpose: To investigate the clinicopathologic effects of cyclosporine A (CsA) in children with diseases characterized by mesangial immunoglobulin A deposits such as immunoglobulin A nephropathy (IgAN) and Henoch-Schönlein purpura nephritis (HSPN). Methods: We retrospectively reviewed the clinicopathologic outcomes of 54children (IgAN, 36; HSPN, 18) treated with CsA. The starting dose of CsA was 5mg/kg per day, and it was administered in 2 divided doses. The degree of proteinuria and pathologic changes in renal biopsies were evaluated before and after CsA treatment. Results: The mean protein to creatinine ratio decreased from 3.7±1.5 to 0.6±0.4(P <0.001), and 32 (59.2%) children achieved complete remission of proteinuria after 1-year CsA treatment. Among the 54 children, 24 maintained normal renal function and 25 exhibited microscopic hematuria or proteinuria at the end of CsA treatment. In the HSPN group, 3 children whose initial biopsies indicated class IIIb disease showed class II disease on follow-up, and the follow-up biopsies of 2children who had class II disease indicated the same class II disease. In the IgAN group, cortical tubular atrophy occurred in 1 child, and no child with IgAN had cortical interstitial fibrosis or tubular atrophy after 1-year CsA treatment. No significant complications were found in the children treated with CsA. Conclusion: Our findings indicate that CsA treatment is effective and beneficial in reducing massive proteinuria and preventing progression to end-stage renal failure in children with glomerular diseases characterized by IgA deposits, such as IgAN and HSPN, within 1 year of treatment.
URI
http://hdl.handle.net/YU.REPOSITORY/28714
ISSN
1226-5292
Appears in Collections:
의과대학 > 병리학교실 > Articles
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE